Fractionated vaccination with mRNA COVID‐19 vaccine is safe for patients with polyethylene glycol allergy
Open Access
- 21 January 2023
- journal article
- letter
- Published by Wiley in Clinical and Translational Allergy
- Vol. 13 (1) , e12217
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Polyethylene Glycol Allergy and Immediate-Type Hypersensitivity Reaction to COVID-19 Vaccination: Case ReportJournal of Investigational Allergology and Clinical Immunology, 2022
- Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case seriesThe Journal of Allergy and Clinical Immunology: In Practice, 2021
- Experience with polyethylene glycol allergy‐guided risk management for COVID‐19 vaccine anaphylaxisAllergy, 2021
- The form of PEG matters: PEG conjugated with lipids and not PEG alone could be the specific form involved in allergic reactions to COVID‐19 vaccinesAllergy, 2021
- The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus ApproachThe Journal of Allergy and Clinical Immunology: In Practice, 2021
- Patients with suspected allergic reactions to COVID‐19 vaccines can be safely revaccinated after diagnostic work‐upClinical and Translational Allergy, 2021
- Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccinesJournal of Allergy and Clinical Immunology, 2021
- Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer/BioNTech mRNA COVID‐19 vaccineClinical & Experimental Allergy, 2021
- Anaphylaxis to the first COVID-19 vaccine: is polyethylene glycol (PEG) the culprit?British Journal of Anaesthesia, 2021
- Immediate Hypersensitivity to Polyethylene Glycols and Polysorbates: More Common Than We Have RecognizedThe Journal of Allergy and Clinical Immunology: In Practice, 2019